  See all
 |
Articles: Lung/Thoracic Oncology |
Prior Articles
Lung cancer susceptibility and genetic polymorphism of DNA repair gene XRCC4 in Taiwan
Cancer Biomarkers, 09/10/09
P53 and p38 MAPK pathways are involved in MONCPT-induced cell cycle G2/M arrest in human non-small cell lung cancer A549
Journal of Cancer Research & Clinical Oncology, 09/10/09 Adenovirus-mediated transfer of siRNA against survivin enhances the radiosensitivity of human non-small cell lung cancer cells
Cancer Gene Therapy, 09/10/09 Best supportive care in lung cancer trials is inadequately described
European Journal of Cancer Care, 09/09/09 Vorinostat increases carboplatin and paclitaxel activity in non-small cell lung cancer cells
International Journal of Cancer, 09/08/09 Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation
Clinical Cancer Research, 09/08/09 Lung cancer in a health area of Spain: incidence, characteristics and survival
European Journal of Cancer Care, 09/08/09 Increased tryptophan degradation in patients with bronchus carcinoma
European Journal of Cancer Care, 09/08/09 Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer
Journal of Clinical Oncology, 09/04/09 A phase II study of weekly docetaxel-cisplatin as first-line treatment for advanced non-small cell lung cancer
Journal of Thoracic Oncology, 09/04/09 The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma
Histopathology, 09/04/09 Expression profiles of thioredoxin family proteins in human lung cancer tissue: correlation with proliferation and differentiation
Histopathology, 09/04/09 Frequency of and variables associated with the EGFR mutation and its subtypes
International Journal of Cancer, 09/04/09 Serum osteopontin levels are highly prognostic for survival in advanced non-small cell lung cancer: results from JMTO LC 0004
Journal of Thoracic Oncology, 09/03/09 Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
The Lancet Oncology - Online First, 09/03/09 IFCT-0401 trial: A phase II study of gefitinib administered as first-line treatment in advanced adenocarcinoma with bronchioloalveolar carcinoma subtype
Journal of Thoracic Oncology, 09/03/09 Cannabis, tobacco and domestic fumes intake are associated with nasopharyngeal carcinoma in North Africa
British Journal of Cancer, 09/03/09 TGFBR1 Haplotypes and Risk of Non–Small-Cell Lung Cancer
Cancer Research, 09/03/09 Activation of thromboxane A2 receptors induces orphan nuclear receptor Nurr1 expression and stimulates cell proliferation in human lung cancer cells
Carcinogenesis, 09/03/09 A phase I/II study of gti-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer: a study of the PMH Phase II Consortium
Journal of Thoracic Oncology, 09/02/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
